Virtual Data Rooms: The Unsung Hero of Biotech Financing
Andreessen Horowitz
FEBRUARY 13, 2024
The biotech industry is built on one of the cleanest go-to-market strategies in existence: if you make a safe drug that really works, patients are likely to receive it and payors are likely to pay for it. This simplicity is of course shrouded in the complexity of biology, and demands that biotech companies thoughtfully de-risk existential concerns throughout the drug development lifecycle.
Let's personalize your content